JP2022544803A5 - - Google Patents
Info
- Publication number
- JP2022544803A5 JP2022544803A5 JP2022510087A JP2022510087A JP2022544803A5 JP 2022544803 A5 JP2022544803 A5 JP 2022544803A5 JP 2022510087 A JP2022510087 A JP 2022510087A JP 2022510087 A JP2022510087 A JP 2022510087A JP 2022544803 A5 JP2022544803 A5 JP 2022544803A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- methyl
- hydrogen
- oxo
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19192107 | 2019-08-16 | ||
| EP19192107.1 | 2019-08-16 | ||
| PCT/EP2020/072911 WO2021032643A1 (en) | 2019-08-16 | 2020-08-14 | Compounds suitable for the treatment and prophylaxis of muscle wasting and other conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022544803A JP2022544803A (ja) | 2022-10-21 |
| JP2022544803A5 true JP2022544803A5 (enExample) | 2023-08-17 |
Family
ID=67659191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510087A Pending JP2022544803A (ja) | 2019-08-16 | 2020-08-14 | 筋肉消耗及び他の状態の治療及び予防に好適な化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12331042B2 (enExample) |
| EP (1) | EP4013497B1 (enExample) |
| JP (1) | JP2022544803A (enExample) |
| KR (1) | KR20220047807A (enExample) |
| CN (1) | CN114302881B (enExample) |
| AU (1) | AU2020334194A1 (enExample) |
| BR (1) | BR112022002769A2 (enExample) |
| CA (1) | CA3144700A1 (enExample) |
| CL (1) | CL2022000320A1 (enExample) |
| IL (1) | IL290540A (enExample) |
| MX (1) | MX2022002022A (enExample) |
| WO (1) | WO2021032643A1 (enExample) |
| ZA (1) | ZA202202863B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102823820B1 (ko) * | 2022-09-01 | 2025-06-23 | 단국대학교 천안캠퍼스 산학협력단 | 퓨로크로멘온계 화합물을 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학 조성물 |
| WO2024068809A1 (en) * | 2022-09-30 | 2024-04-04 | Société des Produits Nestlé S.A. | Composition and method for treating muscle decline associated with renal disease or dysfunction |
| KR102995500B1 (ko) * | 2024-11-07 | 2026-07-23 | 아주대학교산학협력단 | 근감소증의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200803016B (en) * | 2005-09-29 | 2009-10-28 | Elan Pharmaceuticals Inc Wyeth | Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| EP2072528A1 (en) | 2007-12-19 | 2009-06-24 | Labeit, Mr. Siegfried | A host cell deficient for MuRF1 and MuRF2 |
| US20140161729A1 (en) * | 2011-04-07 | 2014-06-12 | Cornell University | Cofluorons and methods of making and using them |
| CN106822153B (zh) * | 2011-06-06 | 2019-12-17 | 爱荷华大学研究基金会 | 用于抑制肌萎缩的方法 |
| AU2014290368B2 (en) * | 2013-07-18 | 2019-07-11 | Baylor College Of Medicine | Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia |
| WO2015050984A1 (en) * | 2013-10-01 | 2015-04-09 | New York University | Amino, amido, and heterocyclic compounds as modulators of rage activity and uses thereof |
| CN112274183A (zh) * | 2020-11-02 | 2021-01-29 | 李云莹 | 一种神经内科用脑部超声波治疗装置 |
-
2020
- 2020-08-14 CN CN202080057706.5A patent/CN114302881B/zh active Active
- 2020-08-14 EP EP20764952.6A patent/EP4013497B1/en active Active
- 2020-08-14 CA CA3144700A patent/CA3144700A1/en active Pending
- 2020-08-14 US US17/634,174 patent/US12331042B2/en active Active
- 2020-08-14 BR BR112022002769A patent/BR112022002769A2/pt not_active Application Discontinuation
- 2020-08-14 WO PCT/EP2020/072911 patent/WO2021032643A1/en not_active Ceased
- 2020-08-14 AU AU2020334194A patent/AU2020334194A1/en not_active Abandoned
- 2020-08-14 MX MX2022002022A patent/MX2022002022A/es unknown
- 2020-08-14 JP JP2022510087A patent/JP2022544803A/ja active Pending
- 2020-08-14 KR KR1020227007940A patent/KR20220047807A/ko not_active Ceased
-
2022
- 2022-02-08 CL CL2022000320A patent/CL2022000320A1/es unknown
- 2022-02-10 IL IL290540A patent/IL290540A/en unknown
- 2022-03-09 ZA ZA2022/02863A patent/ZA202202863B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022510313A5 (enExample) | ||
| RU2494095C2 (ru) | Модифицированные миметики лизина | |
| JP2021513534A5 (enExample) | ||
| JP2014502979A5 (enExample) | ||
| JP2021516240A5 (enExample) | ||
| JP2023529354A5 (enExample) | ||
| JP2019094345A5 (enExample) | ||
| JP2021535164A5 (enExample) | ||
| JP2015524443A5 (enExample) | ||
| JP2021529185A5 (enExample) | ||
| JP2005513123A5 (enExample) | ||
| JP2009536620A5 (enExample) | ||
| JP2005522438A5 (enExample) | ||
| RU2013138569A (ru) | Антагонисты рецептора минералокортикоидов | |
| JPWO2023195529A5 (enExample) | ||
| JP2021535174A5 (enExample) | ||
| JP2016523923A5 (enExample) | ||
| JP2020111571A5 (enExample) | ||
| JP2024508526A5 (enExample) | ||
| JP2016519106A5 (enExample) | ||
| JP2010527985A5 (enExample) | ||
| JP2020511450A5 (enExample) | ||
| RU2374228C2 (ru) | Производные 4-фенилпиперидина в качестве ингибиторов ренина | |
| JP2022537350A5 (enExample) | ||
| RU2015150287A (ru) | Новые соединения 3,4-дигидро-2н-изохинолин-1-она и 2,3-дигидроизоиндол-1-она |